期刊文献+

血尿对细胞学和荧光原位杂交检测膀胱肿瘤结果的影响 被引量:2

Effect of hematuria on the performance of cytology and fluorescence in situ hybridization in the detection of bladder carcinoma
下载PDF
导出
摘要 目的:探讨血尿对细胞学和荧光原位杂交(fluorescence in situ hybridization,FISH)检测膀胱肿瘤结果的影响。方法:2009年1月至2013年6月,164例可疑膀胱癌的患者均接受尿脱落细胞学、FISH、上尿路影像学检查和膀胱镜检等检查,对可疑病变取活检或(和)切除术。比较血尿对细胞学和FISH假阳性率和假阴性率的影响。结果:血尿和无血尿患者细胞学假阳性率分别为14.3%和20.9%(χ2=0.645,P=0.422),假阴性率分别为21.4%和39.1%(χ2=2.618,P=0.106);FISH假阳性率分别为19.0%和20.9%(χ2=0.047,P=0.828),假阴性率分别为30.3%和30.4%(χ2=0.002,P=0.967),均无统计学差异。结论:血尿不会影响细胞学和FISH检测膀胱肿瘤的结果。 Objective:To access the influence of hematuria on the performance of urine cytology(CYT)and fluorescence in situ hybridization(FISH)in the detection of bladder carcinoma(BC). Methods:From January 2009 to June 2013,a total of 164 patients suspicious of BC underwent tests of CYT and FISH followed by upper urinary tract imaging and cystoscopy. Transurethral biopsy and/or resection were performed on suspicious lesions. The hematuria was determined by urine microscopy. Effect of hematuria on false positive and negative rates of patients with and without BC was compared. Results:For patients with hematuria,false positive rates of CYT were 14.3% and 20.9%(χ^2=0.645,P=0.422)and false negative rates of CYT were 21.4% and 39.1%(χ^2=2.618,P=0.106);false positive rates of FISH were 19.0% and 20.9%(χ^2=0.047,P=0.828) and false negative rates of FISH were 30.3% and 30.4%(χ^2=0.002,P=0.967)all without statistical difference. Conclusion:Hematuria does not influence the performance of CYT and FISH.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2014年第9期1312-1316,共5页 Journal of Chongqing Medical University
基金 贵州省科技厅基金资助项目(编号:黔科合J字[2011]2249号)
关键词 血尿 尿脱落细胞学检查 荧光原位杂交技术 膀胱癌 hematuria cytological examination fluorescence in situ hybridization bladder cancer
  • 相关文献

参考文献13

  • 1Roupret M,Zigeuner R,Palou J,et al.European guidelines for the diagnosis and management of upper urinary tract urothelial cell carci- nomas:2011 update[J].Eur Urol,2011,59(4) :584-594.
  • 2Dal Mow F,Valotto C,Gnttilla A,et al.Urinary markers in the ev- eryday diagnosis of bladder cancer[J].Urologia, 2013,80 (4) : 265-275.
  • 3Ho CC,Tan WP,Pathmanathan R,et al.Fluorescenee-in-situ-hy- bridization in the surveillance of urothelial cancers :can use of cys- toscopy or ureteroscopy be deferred?[J].Asian Pac J Cancer Prev,2013, 14(7) :4057-4059.
  • 4Shariat SF,Marberger MJ,Lotan Y,et al.Variabihty in the perfor- mance of nuclear matrix protein 22 for the detection of bladder cancer [J].J Urol, 2006,176 (3) : 919-926; discussion 926.
  • 5Todenhofer T ,Hennenlotter ],Tews V, et al.lmpaet of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma[J].Urol Oncol, 2013, 31(7) : 1148-1154.
  • 6Pesch B,Nasterlack M,Eberle F,et al.The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines[J].BJU Int, 2011,108(4) : 546-552.
  • 7Karakiewicz PI,Benayoun S,Zippe C,et al.lnstitutional variability in the accuracy of urinary cytology for predicting recurrence of transi- tional cell carcinoma of the bladder[J].BJU Int,2006,97(5):997-1001.
  • 8Todenhofer T,Hennenlotter J,Kuhs U,et al.lnfluence of urinary tract instrumentation and inflammation on the performance of urine markers for the detection of bladder eaneer[J].Urology, 2012,79 (3) : 620-624.
  • 9Atsu N,Ekici S,Oge OO,et al.False-positive results of the NMP22 test due to hematuria[J].J Urol,2002,167(2Ptl) :555-558.
  • 10Oge O,Kozaci D,Gemalmaz H.The BTA star test is nonspecifie for hematuria : an experimental hematuria model [J].J Urol, 2002, 167 ( 3 ) : 1318-1319; discussion 1319-1320.

同被引文献18

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部